Streetbeat News

Regulatory

NVAX

Novavax has submitted an application for its monovalent vaccine targeting the XBB 1.5 sub variant to the European Medicines Agency (EMA), according to EMA Director Emer Cooke. The announcement was made during an ECDC press conference.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:24 pm

IOT

Spruce Point Capital Management has released a report expressing a strong sell opinion on Samsara Inc. (NYSE:IOT). The report highlights concerns over Samsara's accounting policies, financial reporting, revenue growth risks, competitive position, and governance. It also questions the company's upside potential related to AI and sees a 45% to 75% long-term downside risk to Samsara's share price.

Portfolio Pulse from Happy Mohamed

September 21, 2023 | 1:20 pm

BTCUSD

The rehabilitation trustee of Mt. Gox, once the world's largest Bitcoin exchange, has announced a postponement in its repayment deadlines to Oct. 31, 2024. The decision comes as the trustee grapples with the complexities of gathering necessary information from rehabilitation creditors and coordinating with associated banks, fund transfer service providers, and designated crypto exchanges. Those who have already provided the necessary information can expect their repayments to commence as early as the end of this year.

Portfolio Pulse from Murtuza Merchant

September 21, 2023 | 1:19 pm

NBIX

Neurocrine Biosciences has presented a post hoc data analysis on Congenital Adrenal Hyperplasia at the ESPE 2023 conference. The company's findings could potentially impact future treatments for the condition.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:17 pm

AYRO

AYRO, Inc., a designer and manufacturer of electric delivery vehicles, has secured its second design patent for additional components of the AYRO Vanish. The patent pertains to the common chassis base profile and reconfigurable cargo subsystems of the Vanish. This is part of several patents that AYRO has applied for as part of the vehicle's design. The company has also been honored with two prominent awards in 2023, the Red Dot Award for Product Design and the Frost and Sullivan North American New Product Innovation Award.

Portfolio Pulse from Happy Mohamed

September 21, 2023 | 1:15 pm

HGBL

Heritage Global Inc. has announced the filing of Form S-3 to replace its expired shelf registration statement. This move allows the company to sell securities in the future without a delay.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:03 pm

PRPO

Precipio has taken the final step towards regaining compliance with Nasdaq's listing requirements. The company's stock, PRPO, is expected to remain listed on the exchange.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:01 pm

KRYS

Krystal Biotech has announced that the FDA has cleared its Investigational New Drug application for KB408, a treatment for Type 1 Alpha-1 Antitrypsin Deficiency. Additionally, KB408 has been granted Orphan Drug Designation.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 1:01 pm

IMMX

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Immix Biopharma's NXC-201 for the treatment of Amyloid Light Chain (AL) Amyloidosis. The designation qualifies NXC-201 for 7 years of U.S. market exclusivity after approval, tax credits for qualified clinical testing, and a waiver of the Prescription Drug User Fee. The Amyloidosis market was $3.6 billion in 2017 and is expected to reach $6 billion in 2025.

Portfolio Pulse from Happy Mohamed

September 21, 2023 | 12:55 pm

VFS

Vietnamese electric vehicle manufacturer VinFast Auto Ltd (NASDAQ:VFS) plans to ship its first batch of EVs to Europe this year after regulatory approval. The company aims to ship about 3,000 of its VF8 crossovers to France, Germany, and the Netherlands in Q4. If successful, Europe will be VinFast's biggest overseas market in 2023. The company is also working to obtain the voluntary Euro NCAP safety rating. VFS shares are trading lower by 0.70% at $17.07 in premarket on the last check Thursday.

Portfolio Pulse from Shivani Kumaresan

September 21, 2023 | 12:54 pm